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ABSTRACT Bacterialbioﬁlmsoftenformmultispeciescommunitiesinwhichcomplexbutill-understoodcompetitionandcoop-
erationinteractionsoccur.Inlightoftheprofoundphysiologicalmodiﬁcationsassociatedwiththislifestyle,wehypothesized
thatthebioﬁlmenvironmentmightrepresentanuntappedsourceofnaturalbioactivemoleculesinterferingwithbacterialadhe-
sion or bioﬁlm formation. We produced cell-free solutions extracted from in vitro mature bioﬁlms formed by 122 natural Esche-
richia coli isolates, and we screened these bioﬁlm extracts for antiadhesion molecules active on a panel of Gram-positive and
Gram-negativebacteria.Usingthisapproach,weshowedthat20%ofthetestedbioﬁlmextractscontainedmoleculesthatantag-
onize bacterial growth or adhesion. We characterized a compound, produced by a commensal animal E. coli strain, for which
activityisdetectedonlyinbioﬁlmextract.Biochemicalandgeneticanalysesshowedthatthiscompoundcorrespondstoanew
typeofreleasedhigh-molecular-weightpolysaccharidewhosebioﬁlm-associatedproductionisregulatedbytheRfaHprotein.
WedemonstratedthattheantiadhesionactivityofthispolysaccharidewasrestrictedtoGram-positivebacteriaandthatitspro-
duction reduced susceptibility to invasion and provided rapid exclusion of Staphylococcus aureus from mixed E. coli and S. au-
reusbioﬁlms.Ourresultsthereforedemonstratethatbioﬁlmscontainmoleculesthatcontributetothedynamicsofmixedbacte-
rialcommunitiesandthatarenotoronlypoorlydetectedinunconcentratedplanktonicsupernatants.Systematicidentiﬁcation
ofthesecompoundscouldleadtostrategiesthatlimitpathogensurfacecolonizationandreducetheburdenassociatedwiththe
developmentofbacterialbioﬁlmsonmedicaldevices.
IMPORTANCE Wesoughttodemonstratethatbacterialbioﬁlmsarereservoirsforunknownmoleculesthatantagonizebacterial
adhesion. The use of natural strains representative of Escherichia coli species biodiversity showed that nonbiocidal antiadhesion
polysaccharidesarefrequentlyfoundinmaturebioﬁlmextracts(bacterium-freesuspensionswhichcontainsolublemolecules
producedwithinthebioﬁlm).Releaseofanantiadhesionpolysaccharideconfersacompetitiveadvantageupontheproducing
strain against clinically relevant pathogens such as Staphylococcus aureus. Hence, exploring the bioﬁlm environment provides a
betterunderstandingofbacterialinteractionswithincomplexcommunitiesandcouldleadtoimprovedcontrolofpathogencol-
onization.
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T
he development of matrix-encased bioﬁlm communities on
medical implants challenges most treatments of bacterial in-
fectionsduetohighbioﬁlmtolerancetoantibiotics(1).Toreduce
trauma and cost associated with physical removal of recalcitrant
bioﬁlms, several approaches have been proposed to eliminate al-
ready formed bioﬁlms, including the use of dispersion molecules
(2, 3), antimicrobial compounds active against bioﬁlm bacteria
(4), bacterial communication inhibitors (5), and even biological
entities such as bacteriophages (6) or grazing organisms that feed
on bioﬁlm bacteria (7).
Many of these strategies are impractical in medical settings,
and early prevention of the initial adhesion stages of bioﬁlm for-
mation by coating patient care equipment with antibiotics or
other biocides is thus considered a promising, straightforward
approach (8, 9). However, toxicity issues and the onset of resis-
tance associated with biocidal coatings have fostered interest in
nonbiocidal solutions using tensioactive molecules or materials
having antiadhesion properties (8). These approaches could rep-
resent a safe and effective means of controlling infection, since a
decrease in bacterial pathogen colonization on critical surfaces
would also impede a crucial step in bacterial pathogenesis (10).
Several nonbiocidal surface-active agents produced by micro-
organisms were shown to modify microbial interactions with the
environment (11). For instance, rhamnolipids produced by the
opportunistic pathogen Pseudomonas aeruginosa impair bacterial
bioﬁlms (12), several biosurfactants or bioemulsiﬁers produced
by marine bacteria display antibioﬁlm activity against pathogenic
bacteria (13), and we have previously shown that soluble polysac-
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cochemical surface modiﬁcations, preventing bioﬁlm formation
by a wide range of Gram-positive and Gram-negative bacteria
(14). Hence, microbe-derived compounds that affect wettability,
detergency,andotheramphipath-relatedpropertiescouldpoten-
tially be used to regulate the attachment or detachment of micro-
organisms to or from surfaces (15).
Although bioﬁlms represent an ideal environment for antago-
nistic and synergistic interactions, production and release of such
moleculeshavebeenstudiedmainlyunderliquidplanktoniccon-
ditions. However, the bioﬁlm lifestyle is known to trigger physio-
logical and metabolic adjustments, potentially leading to produc-
tion of bioﬁlm-associated molecules (16, 17). Therefore, bioﬁlms
could represent untapped sources of natural bioactive molecules
that antagonize adhesion or bioﬁlm formation, potentially inﬂu-
encing the dynamics of bacterial populations in mixed-species
contexts (18).
Here we hypothesized that soluble molecules could accumu-
late within mature bioﬁlms formed by natural commensal and
pathogenic isolates representative of the biodiversity of the E. coli
species. We identiﬁed several such bioﬁlm-associated molecules
displaying antiadhesion properties, including a high-molecular-
weight polysaccharide active only against Gram-positive bacteria,
the activity of which is otherwise poorly detected in unconcen-
tratedplanktonicsupernatants.Weprovidegeneticandbiochem-
icalevidencethatthisbioﬁlm-associatedmoleculecorrespondsto
a newly released polysaccharide regulated by the RfaH protein.
Our results therefore experimentally demonstrate that high-cell-
density bioﬁlms constitute unexplored reservoirs of bacterial in-
terference molecules that could limit bioﬁlm formation and con-
trol of pathogen bioﬁlm colonization.
RESULTS
BioﬁlmsformedbynaturalE.coliisolatescontainsolubleanti-
adhesion molecules. To identify E. coli bioﬁlm-associated mole-
cules that potentially prevent bacterial adhesion, we produced
mature bioﬁlms from 122 commensal and pathogenic E. coli
strains of human and animal origin representative of the ecologi-
TABLE 1 E. coli strains displaying antibioﬁlm activity in bioﬁlm extracts
Straina Pathovarf
Phylogenetic
group
Group II
capsuleb
Activity spectrum
Bioﬁlm
extract
Planktonic
supernatant
K-12 MG1655 NDc AN D N D N D
DAEC18 DAEC B2 Dc S. aureus, E. faecalis,
E. coli K-12, E. cloacae,
K. pneumoniae
S. aureus, E. coli K-12,
E. cloacae, K. pneumoniae
IAI37 UPEC A1 D E. faecalis, E. coli K-12,
E. cloacae, K. pneumoniae
E. coli K-12, E. cloacae,
K. pneumoniae
IAI44 UPEC A1 ND E. coli K-12 E. coli K-12
IAI71 UPEC B22 D E. coli K-12 E. coli K-12
IAI73 UPEC B23 ND S. aureus, E. coli K-12,
K. pneumoniae
S. aureus, E. coli K-12,
K. pneumoniae
Ec111d
(ROAR111)
Commensal B1 ND S. aureus ND
ROAR212 Commensal A ND S. aureus S. aureus
Ec300e
(ROAR300)
Commensal A ND S. aureus, S. epidermidis,
E. faecalis
ND
ROAR319 Commensal B1 ND S. aureus, E. cloacae S. aureus
ROAR381 Commensal A D E. coli K-12, K. pneumoniae E. coli K-12, K. pneumoniae
DAEC9 DAEC D D E. coli K-12, K. pneumoniae E. coli K-12, K. pneumoniae
ROAR002 Commensal A ND E. coli K-12, K. pneumoniae E. coli K-12, K. pneumoniae
ROAR029 Commensal D ND E. coli K-12 ND
ROAR194 Commensal A1 ND S. aureus, E. cloacae S. aureus, E. cloacae
ROAR057 Commensal B1 D E. coli K-12 E. coli K-12
ROAR248 Commensal D ND S. aureus S. aureus, E. faecalis,
E. coli K-12
H-19 EHEC B1 ND E. coli K-12, S. epidermidis E. coli K-12, S. epidermidis
ROAR094 Commensal D ND E. coli K-12 E. coli K-12
ROAR206 Commensal D ND E. coli K-12, K. pneumoniae K. pneumoniae
C1845 DAEC B2 D S. aureus, E. coli K-12 S. aureus, E. coli K-12
289KH89 NPEC A ND E. coli K-12 E. coli K-12
ROAR066 Commensal B1 ND S. aureus S. aureus
ROAR208 Commensal C ND E. coli K-12 E. coli K-12
RS218 ExPEC B2 D S. aureus, E. coli K-12 S. aureus, E. coli K-12
a See Table S1 in the supplemental material.
b Presence of genes involved in biosynthesis of group 2 capsule.
c ND, not detected; D, detected.
d Commensal strain from the B1 phylogenetic group isolated from a roe deer (Capreolus capreolus) in the Fontainebleau forest (France) (Table S1).
e Commensal strain of the A phylogenetic group collected from a dog (Canis familiaris) in the Pyrenees mountains (France) (Table S1).
f DAEC, diffusely adhering E. coli; UPEC, uropathogenic E. coli; EHEC, enterohemorrhagic E. coli; NPEC, nonpathogenic E. coli; ExPEC, extraintestinal pathogenic E. coli.
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in the supplemental material). We recovered the bioﬁlm biomass
formedafter72hofgrowthandﬁlteredtheresuspensionsolution.
This bacterium-free suspension, which contains soluble mole-
cules produced within the bioﬁlm, will here be referred to as bio-
ﬁlm extract (Fig. S1A). We then tested each bioﬁlm extract for
potentialantibioﬁlmactivityusingmicrotiterplatewells,contain-
ing a 1:1 ratio of bioﬁlm extract to growth medium, and inocu-
lateditwithapanelofbioﬁlm-formingGram-negativeandGram-
positive bacteria, including E. coli K-12 MG1655 carrying an F
conjugative plasmid and strain O42, Enterobacter cloacae 1092,
Pseudomonas aeruginosa PAK retS, Klebsiella pneumoniae 21,
Staphylococcus aureus 15981, Staphylococcus epidermidis O-47,
and Enterococcus faecalis 54 (Fig. S1B).
Thisscreenledtotheidentiﬁcationof24naturalE.coliisolates
with bioﬁlm extracts active against at least one of the bioﬁlm-
forming bacteria included in our test panel (Table 1; see also
Fig. S1B in the supplemental material). Among these 24 active
strains, we discarded 8 strains whose genomes contained genes
responsible for production of the previously demonstrated anti-
adhesive group 2 capsule (14), and most of them lost antibioﬁlm
activityupondeletionofkpsD,ageneessentialforgroup2capsule
secretion (Table 1).
Inhibition of bioﬁlm formation by the remaining 16 selected
active strains could result from the limitation of bacterial adhe-
sion,bacteriostaticorbacteriocidalactivity,orbioﬁlmdispersion.
We ﬁrst tested potential bacteriostatic or bacteriocidal activity by
spotting aliquots of active bioﬁlm extracts on bacterial lawns
formedbytheGram-negativeandGram-positivestrainsincluded
in our test panel. With the exception of E. coli ROAR029, which
displayed growth-inhibiting activity against E. coli K-12, no other
growth inhibition zone could be detected (data not shown). This
suggested that bioﬁlm inhibition induced by the 15 remaining
bioﬁlm extracts was not the consequence of a growth inhibition
(Table 1 and data not shown). Finally, addition of prepared bio-
ﬁlm extracts did not lead to signiﬁcant bioﬁlm dispersion when
added to 24-h bioﬁlms formed in microtiter plates by all tested
bacteria (data not shown). These results therefore indicated that
FIG1 Effect of planktonic and bioﬁlm extracts upon S. aureus bioﬁlm formation. (A) S. aureus bioﬁlm inhibition upon addition of planktonic (Pk) or bioﬁlm
(Bf) extracts from indicated E. coli strains. M63B1, control in which only M63B1 minimal medium was added. Statistical t tests were used to evaluate the
signiﬁcanceofplanktonic(Pk)andbioﬁlm(Bf)extractinhibition.***,P0.001.(B)S.aureusbioﬁlminhibitionwithnonconcentratedE.coliEc300andEc111
bioﬁlmextracts(ncBfextract)orwithpuriﬁedpolysaccharidespresentinE.coliEc300andEc111bioﬁlmextracts(puriﬁedBfEc300pandEc111p,respectively).
(C) Comparison of speciﬁc antibioﬁlm activities over S. aureus of Ec300 polysaccharide concentrated from the planktonic supernatant (conc Ec300p Pk) or
bioﬁlmextract(concEc300pBf).Thexaxisunitscorrespondtothepolysaccharidicconcentration(comparedtoaglucosestandard)ing/ml.Experimentswere
performed at least in triplicate; error bars represent standard deviations of the means.
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adhesionactivitiesthatcouldnotbeattributedtothesolublemol-
ecules previously described in E. coli.
Identiﬁcation of two new bioﬁlm-associated antiadhesion
polysaccharides. Among the 15 active extracts identiﬁed by our
screen, bioﬁlm extracts from E. coli Ec300 and Ec111, two com-
mensal animal E. coli strains belonging to the A and B1 phyloge-
neticgroups,respectively(Table1;seealsoTableS1inthesupple-
mental material), displayed signiﬁcantly higher antiadhesion
activities than their respective planktonic supernatants (Fig. 1A).
This observation contrasted both with strains that displayed anti-
adhesion activity in bioﬁlm and planktonic extracts (Fig. 1A,
strain ROAR319) and with inactive E. coli strains (Fig. 1A, strain
MG1655). This indicated that the E. coli Ec300 and Ec111 antiad-
hesion molecules were speciﬁcally associated with mature bioﬁlm
conditions (Fig. 1A). Both Ec300 and Ec111 bioﬁlm extract anti-
adhesion activities were retained in fractions corresponding to a
molecularmasscutoffabove100kDa,andbothwerehighlyresis-
tant to proteinase K and heat treatment, three properties indica-
tive of high-molecular-weight polysaccharide polymers (data not
shown). Indeed, as shown in Fig. 1B, concentrated and puriﬁed
(see Materials and Methods) Ec300 and Ec111 polysaccharides
(termed Ec300p and Ec111p, respectively) exhibited comparable
antibioﬁlm activities. Both polysaccharides displayed molecular
masses above 500, as indicated by gel ﬁltration analysis (data not
shown), and although puriﬁed Ec111p contains more gluco-
samine and galactosamine than Ec300p, both molecules were
composed of mannose, glucose, galactose, and glucuronic acid,
indicating that they were distinct from the previously described
group 2 capsule, which contained galactose, glycerol, phosphate,
and acetate at a molar ratio of 1:2:1:1, respectively (Table 2) (14).
The differences between Ec300p and Ec111p composition may
account for the observed difference of activity, and here, we fo-
cused the rest of the study on the E. coli Ec300 antiadhesion poly-
saccharide,whichdisplayedawideractivityspectrumthanthatof
the Ec111 antiadhesion polysaccharide (Table 1).
E. coli Ec300 bioﬁlm produces more antiadhesion polysac-
charides than comparable planktonic cultures. To investigate
the origin of reduced antiadhesion activity in the E. coli Ec300
planktonic extract, we precipitated, puriﬁed, and quantiﬁed total
soluble polysaccharides extracted either from 24-h stationary-
phaseplanktonicculturesorfromcorrespondingbioﬁlmextracts.
We then compared the speciﬁc activities of these extracts against
that of bioﬁlm formed by S. aureus in microtiter plates and ob-
served that similar quantities of puriﬁed planktonic or bioﬁlm
polysaccharide led to a comparable reduction in S. aureus bioﬁlm
formation (Fig. 1C). This therefore demonstrated that E. coli
Ec300 released small amounts of active Ec300p in planktonic su-
pernatant. Moreover, we determined that the amount of antiad-
hesionpolysaccharideproducedperanequivalentnumberofbac-
teriawas2-foldhigherinE.coliEc300bioﬁlmextractsthaninthe
correspondingplanktonicsupernatants(datanotshown).Hence,
ourresultsindicatedthatproductionofEc300pisnotstrictosensu
bioﬁlm speciﬁc, but its activity is poorly detectable in unconcen-
trated planktonic extracts.
Antiadhesion activity of Ec300p on representative Gram-
positive bacteria is independent of cell wall composition.
WhereasEc300pisnotactiveagainsttestedGram-negativebacte-
ria,itdisplayssigniﬁcantantiadhesionactivityagainstrepresenta-
tive Gram-positive bacteria, including S. aureus, S. epidermidis,
and E. faecalis, without a detectable bactericidal effect (Fig. 2 and
Table 1; see also Fig. S2 in the supplemental material). In order to
determine whether this restricted range of Ec300p antiadhesion
activity was due to Gram-positive bacterial cell wall characteris-
tics, we determined Ec300p activity on bioﬁlm formed by two
S. aureus mutants with altered cell wall properties. We used
HG001 tagO, which lacks teichoic acids, and HG001 dltA,i n
which teichoic acids have no D-alanine esters, leading to a net
negative charge increase (19). Although these two mutants dis-
played reduced bioﬁlm formation capacity compared to that of
the wild-type HG001 strain, addition of E. coli Ec300 bioﬁlm ex-
tract nonetheless further reduced the corresponding bioﬁlm for-
mation (data not shown). We then tested whether the activity of
Ec300p depended on the nature of adhesion factors expressed by
differentS.aureusstrains.WetookadvantageofthefactthatS.au-
reus 15981 bioﬁlm formation is based on production of the poly-
N-acetylglucosamine(PNAG)polymerinthepresenceofglucose
or is protein based in the presence of sodium chloride (20). How-
TABLE 2 Composition of puriﬁed antibioﬁlm polysaccharides by gas-liquid chromatography and high-pressure liquid chromatography
Polysaccharide
Compositiona
Mannose Glucose Galactose Glucosamine Phosphate Glycerol Galactosamine
Glucuronic
acid Acetate Pyruvate Fucose
Group 2
capsule (14)
—— 1 — 1 2— — 1 ——
Colanic
acid (33)
— 1 1.8 — — — — 1 1 1 1.9
Retained
fraction Ec111 Bf
1 0.67 0.52 0.35 0.07 — 0.45 0.18 ND — —
Retained
fraction Ec300 Bf
1 0.26 0.24 0.06 0.06 — 0.02 0.19 ND — —
Ec300
planktonic
1 0.33 0.28 0.03 0.02 — — 0.12 ND — —
Ec300 galF-his 1 1.92 1.05 0.82 0.18 — — — ND ND —
Ec30012208 1 0.19 0.08 — 0.02 — — — ND ND —
K. pneumoniae 342 1 0.27 0.52 0.03 0.04 — — 0.23 ND ND —
a —, not detected; ND, not determined. The composition of puriﬁed retained bioﬁlm fractions from strains Ec111 and Ec300 was tested twice, with no signiﬁcant differences in the
results. The composition of Ec300 mutants and K. pneumoniae 342 was done once. The results are presented in the form of ratios, using mannose, the most abundant
monosaccharide in Ec300p and Ec111p, as the standard.
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still led to a similar reduction in S. aureus bioﬁlm formation
(Fig. S3). These results therefore demonstrated that E. coli Ec300
bioﬁlm extract inhibits representative Gram-positive bacterial
bioﬁlms independently of tested adhesion factors or cell wall net
charge alterations.
Identiﬁcation of genetic determinants of the E. coli Ec300
antiadhesion molecule. To investigate the nature of Ec300p and
genetic regulation behind increased production in the E. coli
Ec300bioﬁlm,weattemptedtoidentifygenesinvolvedinthepro-
duction of Ec300p. We hypothesized that Ec300p genetic deter-
minants could be localized on genomic regions absent in the in-
active E. coli K-12 MG1655 strain (Table 1). Sequencing of the
E.coliEc300genomeusingSolexa(Illumina)technologyrevealed
145 contigs containing E. coli Ec300 genes absent from the
MG1655 genome. We subjected these 145 contigs to a BLAST
search performed on a sliding search window of 1 kb, and we
identiﬁed 5 candidate contigs carrying genes potentially involved
in the biosynthesis, metabolism, and export of Ec300-speciﬁc
polysaccharides (see Table S2 in the supplemental material). The
homology between 4 of these 5 candidate contigs (6759, 12208,
1040, and 9291) and the galF-his region, often encoding colanic
acid, the group 1 capsule, and lipopolysaccharide O antigen (LPS
O antigen) (21), suggested that all four
contigs were located within the E. coli
Ec300 galF-his region (Fig. 3A). Consis-
tently, deletion of the E. coli Ec300 galF-
hisE region abolished bioﬁlm formation
and prevented us from testing the antiad-
hesion activities of the E. coli Ec300 galF-
hisE bioﬁlm extracts (Fig. S4). However,
polysaccharides extracted from the
planktonic supernatant of Ec300 galF-
hisE displayed no antiadhesive activity,
therefore demonstrating that this region
is involved in E. coli Ec300 antiadhesive
activity. Moreover, deletion of contig
2974, which is not included in the E. coli
Ec300 galF-hisE region, did not impact
the activity of the Ec300 supernatant
(Fig. 3; see also Table S2 in the supple-
mental material).
The 40-kb galF-his region of K. pneu-
moniae strain 342 shared homology and
synteny with identiﬁed E. coli Ec300 con-
tigs and was the only bacterial strain dis-
playing homology with contig 12208
(Fig. 3A; see also Table S2 in the supple-
mental material). Consistently, polysac-
charide from K. pneumoniae 342 bioﬁlm
extract inhibited S. aureus bioﬁlm forma-
tionandhadacompositionsimilartothat
of Ec300p (Table 2 and data not shown).
To conﬁrm the implication of the
identiﬁed contigs in the synthesis of
Ec300p, we produced bioﬁlm extracts
from E. coli Ec300 mutants carrying dele-
tions corresponding to all 4 remaining
identiﬁed contigs and tested their ability
to inhibit S. aureus bioﬁlm formation. By
homology with K. pneumoniae 342, contig 9291 is believed to en-
codeLPSOantigen(Fig.3A;seealsoTableS2inthesupplemental
material), and its deletion did not affect the the antiadhesive ac-
tivity of the E. coli Ec300 bioﬁlm extract (Fig. 3B). In contrast,
bioﬁlm extracts from E. coli Ec300 mutants corresponding to de-
letionofcontigs6759,12208,and1040losttheiractivity,therefore
associating these three regions with the antiadhesive activity of
Ec300 supernatant (Fig. 3B). The K. pneumoniae 342 genomic
regionscorrespondingtocontigs6759,12208,and1040contained
genes implicated in colanic acid and group 1 capsule secretion
(Fig. 3A). However, neither analysis of E. coli Ec300 unassembled
genomic contigs nor use of speciﬁc PCR primers (see Table S4)
enabledustodetectthepresenceofgenestypicallyassociatedwith
group 1 capsule or colanic acid biosynthesis, such as wzz and wzy
(21,22).Furthermore,theosidiccompositionratioofEc300pdid
not match with published compositions of colanic acid and the
group 1 capsule, particularly in glucuronic acid, galactose, and
glucose content (Table 2). Concentrated total polysaccharides,
puriﬁed from bioﬁlm extracts or the planktonic supernatant of
E. coli Ec300 deleted from contig 12208, consistently displayed
altered osidic composition and no antiadhesion activity. In addi-
tion, contig 12208 does not contain genes previously described as
being involved in acid colanic or group 1 capsule production (ex-
FIG 2 E. coli Ec300 polysaccharide is only active on Gram-positive bacteria. Bioﬁlm inhibition was
determined in the presence of nonconcentrated E. coli Ec300 bioﬁlm extract (nc Ec300 Bf extract).
Tested representative Gram-positive bacteria include Staphylococcus aureus 15981, Staphylococcus epi-
dermidis 047, and Enterococcus faecalis 54. Gram-negative bacteria tested include Escherichia coli K-12
MG1655 F= tet traD, Enterobacter cloacae 1092, Pseudomonas aeruginosa PAK retS, E. coli 042, and
Klebsiella pneumoniae 21. Statistical t tests were used to evaluate the signiﬁcance of bioﬁlm inhibition
compared to that of fresh media. ***, P  0.001.
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data not shown). Taken together, these results indicated that the
antiadhesive polysaccharide produced by E. coli Ec300 did not
correspondtocolanicacidortothegroup1capsule;thistherefore
suggested that Ec300p corresponded to a new antiadhesive poly-
saccharide.
RegulationofgenesinvolvedinEc300psynthesis.Inorderto
study the regulation of Ec300p production, we analyzed the anti-
adhesion activities of bioﬁlm extracts obtained from strains car-
rying mutations corresponding to regulators previously associ-
ated with bioﬁlm and polysaccharide regulation, including rscB,
luxS, rpoS, oxyR, crr, crp, rpoN, phoP, hns, and rfaH (23). E. coli
FIG 3 The E. coli Ec300 galF-his region is involved in Ec300 polysaccharide production. (A) Schematic alignment of the galF-his region of E. coli Ec300,
K. pneumoniae 342, and E. coli K-12, representing predicted roles of genes in biosynthesis of different polysaccharides. (B) S. aureus bioﬁlm inhibition upon
addition of equivalent nonconcentrated bioﬁlm extracts from indicated E. coli Ec300 derivative strains corresponding to deletions of the contigs potentially
involvedinEc300polysaccharidebiosynthesisoruponadditionofconcentratedplanktonicextractsfromtheE.coliEc300galF-hisEregion(Table2;Fig.3A).Of
note, one of the identiﬁed contigs, contig 2974, does not belong to the galF-his locus. M63B1, control in which only M63B1 minimal medium was added.
Experiments were performed at least in triplicate; error bars represent standard deviations of the means. Statistical t tests were used to evaluate the signiﬁcance
of bioﬁlm inhibition from various extracts. ***, P  0.001.
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activityagainstS.aureusbioﬁlm(Fig.4A).Consistently,introduc-
tionofawild-typerfaHalleleintransatthelambdaattachment
site restored bioﬁlm-associated antiadhesion activity in
Ec300rfaH rfaH (Fig. 4A). RfaH is an antiterminator that
positively controls expression of long operons coding for ex-
tracellularcomponentssuchassecretedvirulencefactors,lipo-
polysaccharide, and conjugation proteins. Although RfaH
binds 12-bp JUMPstart motifs (5=-RGGCGGTAGYNT-3=)o f -
ten located in the promoter-proximal 5= region, analysis of the
DNA region located in the E. coli Ec300 galF-hisE region cor-
respondingtocontigs6759,12208,and1040didnotrevealany
convincing JUMPstart motifs.
To evaluate the potential regulatory role of RfaH, we intro-
duced lacZ transcriptional reporter fusions in front of promoter
regions corresponding to genes located in contigs involved in the
production of Ec300p, including gfcE, etk (contig 6759), genes
homologoustokp1657,andkp1666incontig12208andkp1680in
uninvolved contig 9291 (Fig. 4B; see also Table S2 in the supple-
mentalmaterial).Allfusionswereintroducedintoawild-typeand
E. coli Ec300rfaH lacIZ background; comparison of beta-
galactosidase activities in 24-h planktonic cultures showed that
geneslocatedincontigsinvolvedinthesynthesisofE.coliEc300p
wereregulatedbyrfaH.Incontrast,expressionofthekp1680-lacZ
fusion in nonessential contig 9291 was unaffected by the rfaH
mutation (Fig. 4B).
In order to elucidate increased pro-
duction of Ec300p in E. coli Ec300 bio-
ﬁlms, we compared the expression levels
ofgenesinvolvedinitssynthesisinbacte-
ria harvested during the exponential and
latestationaryphasesaswellasunderbio-
ﬁlm conditions, using lacZ transcrip-
tional fusions. We ﬁrst observed that ex-
pression of etk, 1666, and rfaH increased
betweenexponentialphaseandstationary
growthphasebutdidnotfurtherincrease
in mature bioﬁlm (see Fig. S5 in the sup-
plemental material). Moreover, although
this increased expression was also ob-
served in the nonessential and rfaH-
independent gene kp1680, genes involved
in Ec300p synthesis, such as gfcE and
1657, were not regulated upon entry into
bioﬁlm phase (Table S2 and Fig. S5).
Taken together, these results demon-
strated that, while all tested genes in-
volved in Ec300p synthesis are regulated
byRfaH,somebutnotallofthemareup-
regulated upon entry into stationary and
bioﬁlm phases.
E. coli Ec300 antiadhesion polysac-
charide induces increased surface hy-
drophilicity and impairs S. aureus ini-
tial adhesion. The antiadhesion
properties of Ec300p towards representa-
tive Gram-positive bacteria could result
from a limitation in initial adhesion, pre-
vention of bacterial/bacterial interac-
tions, or both. To investigate this, we ﬁrst
coatedglassslideswithdifferentconcentrationsofEc300p,andwe
observed that this coating resulted in a strong increase in surface
hydrophilicity,evencomparedtothatresultingfromcoatingwith
the group 2 capsule (see Fig. S6 in the supplemental material).
This increased hydrophilicity was not observed with polysaccha-
rides extracted from the E. coli Ec30012208 strain (Fig. S6). We
then tested S. aureus 15981 adhesion on an Ec300p-coated glass
slide and showed that bacterial surface coverage was severely re-
duced after 5 min of incubation in static inoculation suspension,
whereas a similar treatment performed with inactive polysaccha-
ride extracted from an E. coli Ec30012208 bioﬁlm had no effect
(Fig. 5A). We then tested the impact of E. coli Ec300 polysaccha-
ride pretreatment on S. aureus 15981 bioﬁlm formation under
dynamiccontinuous-ﬂowcultureconditionsandshowedthatthe
coatingofaninternalglassslidewithEc300palsoreducedby40%
the amount of bioﬁlm biomass formed in a microfermentor after
24 h of incubation (Fig. 5B). To determine whether Ec300p also
interfered with S. aureus adhesion to components of the eukary-
oticcellextracellularmatrix,suchasﬁbronectin,weusedpolysty-
rene microtiter plate wells coated or not with ﬁbronectin. Addi-
tion of Ec300p at a 1:1 ratio (50 g/ml ﬁnal concentration) right
before bacterial inoculation drastically reduced S. aureus adhe-
sion; an overnight coating of wells with Ec300p prior to bacterial
inoculationhadthesameeffect(Fig.5C).Precoatingofwellswith
ﬁbronectin did not interfere with the antiadhesion activity of
Ec300p (Fig. 5C).
FIG 4 Production of antiadhesion E. coli Ec300 polysaccharide is regulated by rfaH. (A) Effect of
nonconcentrated bioﬁlm extracts from indicated strains on S. aureus bioﬁlm formation. M63B1, con-
trolinwhichonlyM63B1minimalmediumwasadded.(B)Beta-galactosidaseactivitymeasurementsof
lacZ transcriptional fusions in genes located in contigs essential for production of E. coli Ec300 antiad-
hesion polysaccharide in a wild-type and rfaH background. 1680, control; region not involved in
Ec300psynthesis.Experimentswereperformedintriplicate;errorbarsrepresentstandarddeviationsof
the means. Statistical t tests were used to evaluate the signiﬁcance of bioﬁlm inhibition from various
extracts compared to that of addition of M63B1. *, P  0.05; ***, P  0.001.
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bacterial interactions was evaluated by monitoring its capacity to
modulate S. aureus multicellular aggregate formation. S. aureus
aggregation was determined by measuring its sedimentation rate
instaticliquidsolutions.IncontrasttoitseffectonS.aureusinitial
adhesion, addition of Ec300p did not reduce formation of bacte-
rialaggregatesformedbyeitherthemildlyorstronglyaggregating
strains S. aureus 15981 or S. aureus HG001tagO, respectively
(datanotshown).Takentogether,theseresultsstronglysuggested
that the Ec300p antibioﬁlm effect relies on its capacity to impair
initialadhesionofGram-positivebacteria,possiblyduetoitsabil-
ity to increase surface hydrophilicity.
Production of the E. coli Ec300
antiadhesion polysaccharide impairs
initial S. aureus/E. coli interactions in
mixed bioﬁlms. To assess whether pro-
duction of Ec300p also modulates
E. coli/S. aureus interactions, we evalu-
ated the potential consequences of pro-
duction of the E. coli Ec300 antiadhe-
sion molecule in mixed S. aureus/E. coli
Ec300bioﬁlms.Mixedculturesadjusted
to a 1:1 ratio of E. coli Ec300 or
Ec300rfaH to S. aureus were inocu-
lated into several continuous-ﬂow bio-
ﬁlm microfermentors. We then deter-
mined the proportions of the 2 strains
in the bioﬁlm biomass formed in indi-
vidual microfermentors and arrested at
different time points. Although S. au-
reus formed considerably more bioﬁlm
than E. coli Ec300 when inoculated in-
dividually (data not shown), we ob-
served that the proportion of S. aureus
in the resulting E. coli Ec300/S. aureus
mixed bioﬁlm was rapidly reduced, at-
taining only 5% after 40 h of bioﬁlm
culture (Fig. 6A). In contrast, when
S.aureusbioﬁlmwasmixedwiththein-
active E. coli Ec300rfaH mutant at a
1:1 ratio, S. aureus still represented half
of the bioﬁlm biomass after 50 h of bio-
ﬁlm growth (Fig. 6B). This capacity of
E. coli Ec300 to exclude S. aureus from
mixed bioﬁlms was due neither to a
growth competitive advantage, as dem-
onstrated by competition experiments
performed under planktonic condi-
tions, nor to the presence of residual
amounts of antiadhesion polysaccha-
ride present in the E. coli Ec300 inocu-
lum, as revealed by experiments per-
formed with washed and unwashed
E. coli Ec300 bacterial inoculum (data
not shown). Considering Ec300p’s in-
ability to impair S. aureus bacterial/
bacterial aggregation under liquid con-
ditions (see above), these results sug-
gested that the reduction in S. aureus
proportions in mixed S. aureus/E. coli
Ec300 bioﬁlm was due to the production of Ec300p during
E. coli Ec300 bioﬁlm formation. We then studied the impact of
production of Ec300p on S. aureus ability to adhere to pre-
formed E. coli bioﬁlm bacteria by inoculating S. aureus onto
E. coli Ec300 or E. coli Ec300rfaH bioﬁlms grown for8hi n
microfermentors. After 24 h, we observed a 15-fold reduction
intheabilityofS.aureustocolonizeandsettleintoE.coliEc300
bioﬁlm compared to its ability to colonize an E. coli
Ec300rfaH bioﬁlm (Fig. 6C). These results therefore indi-
cated that the competitive advantage exhibited by E. coli Ec300
compared to S. aureus in mixed bioﬁlms correlates with pro-
duction of Ec300p, which inhibits the initial S. aureus surface
FIG5 EffectofEc300antiadhesionpolysaccharideonS.aureusintitialadhesion.(A)S.aureussurface
coverage of a glass slide when the surface was pretreated with either polysaccharides extracted from
E. coli Ec300 or E. coli Ec30012208 at a ﬁnal concentration of 250 g/ml. (B) Reduction in
S. aureus bioﬁlm formation in a continuous-ﬂow microfermentor on a glass surface pretreated in
a solution of 500 g/ml of concentrated Ec300 polysaccharide. (C, top) Interference effect of
addition of Ec300p over S. aureus bioﬁlm formation in microtiter plates coated or not with ﬁ-
bronectin. (Bottom) Corresponding microtiter well bioﬁlm stained with crystal violet. The ﬁgure
of a representative experiment is shown. Experiments were performed in triplicate; error bars
represent standard deviations. Statistical t tests were used to evaluate the signiﬁcance of bioﬁlm
inhibition. **, P  0.01; ***, P  0.001.
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ﬁlms.
DISCUSSION
Bacterial bioﬁlms undergo signiﬁcant gene expression and meta-
bolic modiﬁcations, potentially leading to production of bioﬁlm-
speciﬁc metabolites or polymers (17, 24, 25). Some of these
molecules could display antagonist activities against other micro-
organisms in mixed-species contexts (14, 18). In this study, we
screened mature bioﬁlms formed by commensal and pathogenic
natural E. coli isolates so as to identify such antiadhesion mole-
cules associated with bioﬁlm environments.
Using continuous-ﬂow bioﬁlm microfermentors, our analysis
showed that 20% of tested strains representative of the biodiver-
sity of the E. coli species produce antiadhesion molecules, and at
least10%ofwhichcorrespondtopolysaccharides.Hence,beyond
previouslydescribedgroup2capsuleantiadhesionmolecules,our
resultsdemonstratethewidespreadoccurrenceofpolysaccharides
potentially interfering with the bacterial capacity to interact with
surfaces or other bacteria (14). We fo-
cused our study on the E. coli Ec300 poly-
saccharide (Ec300p) produced by the
commensal isolate E. coli Ec300, since
Ec300p displays original properties in
terms of its spectrum of activity, compo-
sition, and genetic determinants.
A key aspect of our screen resided in
the identiﬁcation of antiadhesion mole-
cules speciﬁc to the bioﬁlm lifestyle.
While many identiﬁed antiadhesion mol-
ecules were seemingly also produced un-
der both planktonic and bioﬁlm condi-
tions, in the case of E. coli Ec300, a
commensal isolate of the A phylogenetic
group, we detected Ec300p antibioﬁlm
activity within thick mature bioﬁlm ex-
tracts. Hence, our results support the hy-
pothesis that bioﬁlms could constitute a
molecularsinkinwhichpolymersandbi-
ologically active molecules are trapped,
and indeed sequestered, compared to
planktonic cultures (26, 27). We showed
that the activity of the concentrated puri-
ﬁed planktonic E. coli Ec300 polysaccha-
ride was similar to that of Ec300p from
bioﬁlm extracts, therefore demonstrating
that E. coli Ec300p production is not
strictly bioﬁlm speciﬁc. However, resus-
pension of mature bioﬁlms used to pro-
duce bioﬁlm extracts consistently con-
tained more bacteria than the equivalent
volume of planktonic culture, and the
high cell density achieved within thick
mature bioﬁlms could explain the detec-
tion of Ec300p activity in bioﬁlm extract
compared to nondetection of activity in
unconcentrated planktonic supernatants,
as previously shown in the case of amino
acid valine accumulation within bioﬁlms
(16).
Nevertheless,wealsodeterminedthattheamountofantiadhe-
sion polysaccharide produced per bacterium was 2-fold higher in
E. coli Ec300 bioﬁlm extracts than in corresponding planktonic
stationary-phase supernatants. This indicated that bioﬁlm-
speciﬁcmetabolismorregulationcouldalsocontributetotheob-
servedbioﬁlm-associatedproductionoftheE.coliEc300polysac-
charide. We show that Ec300p synthesis is positively regulated by
RfaH, which is a transcriptional antiterminator involved in the
regulation of various surface structures (22, 23). However, since
there is no signiﬁcant difference in the rfaH expression level be-
tweenplanktonicstationaryandbioﬁlmgrowthphases,otherreg-
ulatory mechanisms could be involved in bioﬁlm-associated pro-
duction of Ec300p, including, for instance, growth-phase-
dependentregulation.Interestingly,apreviousstudyshowedthat
genes involved in colanic acid production, an RfaH-regulated
process,arealsoinduceduponE.colibioﬁlmformationaspartof
a stress response, suggesting that Ec300p production could result
from increased stress in late stationary phase and bioﬁlms (24).
We determined that genes located in the galF-hisE region en-
FIG 6 Effect of Ec300 antiadhesion polysaccharide production in mixed S. aureus/E. coli Ec300
bioﬁlms.(A)EvolutionofamixedEc300andS.aureusbioﬁlmundercontinuous-ﬂowmicrofermentor
conditions.PercentageofEc300andS.aureusinmixedmicrofermentors,asrevealedbyCFUplatingin
differentialmediaatdifferenttimepoints.wt,wildtype.(B)EvolutionofmixedE.coliEc300rfaHand
S. aureus bioﬁlms under continuous-ﬂow microfermentor conditions. Percentages were obtained as
described above. (C) Ability of S. aureus to colonize preformed E. coli Ec300 or E. coli Ec300rfaH
bioﬁlms formed under continuous-ﬂow microfermentor conditions, as determined by CFU counting
of the different strains. Experiments were performed in triplicate; error bars represent standard devia-
tions of the means. Statistical t tests were used to evaluate the effect of bioﬁlm exclusion upon Ec300p
production. **, P  0.01; ***, P  0.001.
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involved in the synthesis of surface polysaccharides in Enterobac-
teriaceae, including the group 1 capsule, colanic acid, and lipo-
polysaccharideOantigen(21,28).AlthoughneitherEc300pcom-
position nor its genetic determinants match with the O antigen,
group 1 capsule, or colanic acid, we nonetheless identiﬁed genes
involved in group 1 capsule translocation (wzb-wzc) in a region
essential to Ec300p production corresponding to contig 6759
(Fig. 3A). This suggests that E. coli Ec300 produces a new type of
released polysaccharide, potentially exported though heterolo-
gous export machinery.
ThegalF-hisregionisknowntobeastrongholdofE.colichro-
mosome polymorphism (29), with hot spots of both recombina-
tion and gene acquisition and loss (30). Interestingly, whereas
mostgalF-hisregionsidentiﬁedinE.colistrainsextendover16kb
only,theE.coliEc300regionis40kblonganddisplaysahighlevel
of synteny and homology with the galF-his region of K. pneu-
moniae342,whichalsoexhibitedsigniﬁcantantiadhesionactivity.
The presence of several transposases in E. coli Ec300 suggests that
genescodingforEc300pwereacquiredbyhorizontalgenetransfer
into the galF-his locus, potentially from K. pneumoniae 342. In
supportofthishypothesis,genesﬂankingcontigsinvolvedinsyn-
thesis of antiadhesion Ec300p revealed the presence of
transposition-associated genes, and recombination between the
O9-antigen strain and the Klebsiella strain has been previously
reported (31).
Our analysis indicated that the E. coli Ec300 galF-his region
contains genes not involved in the synthesis of Ec300p. Further-
more, the Ec300galF-his mutant lost its ability to produce E. coli
Ec300p and was also unable to form bioﬁlms. This suggested that
the Ec300 galF-hisE region could also encode other nonidentiﬁed
polysaccharides, potentially including O antigen.
The E. coli species releases several high-molecular-weight ex-
tracellular polysaccharides, contributing to bioﬁlm structure as a
componentoftheextracellularmatrix(14,28,32,33).Ourresults
further document that, in addition to functions usually assigned
to bacterial capsules, including promotion of adhesion, masking
of surface adhesins, and resistance to host and environmental
stresses,thereductioninbacterialadhesionbysurface-activebac-
terialpolysaccharidesismorewidespreadthanpreviouslyconsid-
ered.
Bioﬁlms represent an ideal environment in which the study of
antagonisticandsynergisticinteractionscouldbeparticularlyrel-
evantduetobioﬁlmprevalenceinnature.Althoughmuchinterest
has been focused on communication behavior in multispecies
bioﬁlms, the investigation of competitive interference affecting
population dynamics in this context represents a relatively novel
area of interest (18).
In addition to well-known extracellular bacterial antagonist
molecules such as colicins, toxins, and phages (6, 34), surface-
active agents are also likely to affect the dynamics of population
growthonsurfacesbyregulatingtheattachmentordetachmentof
microorganisms to or from surfaces (15). However, the nature
androlesofsurfactantspotentiallyproducedinmixedorcomplex
bacterial community contexts are still poorly understood. Recent
reportshaveshownthathigh-molecular-weightbacterialpolysac-
charidic surfactants could modify population dynamics in a
mixed bioﬁlm context (14). Here we show that, besides Ec300p
antiadhesion activity in vitro, production of E. coli Ec300p results
in very rapid exclusion of S. aureus from mixed E. coli and S. au-
reus bioﬁlms.
Reduction in susceptibility to invasion, or colonization resis-
tance, is a very well-known but undeﬁned community property
shown to strongly depend on species composition (35). Here we
also showed that E. coli Ec300 bioﬁlms producing Ec300p are sig-
niﬁcantly protected from further colonization by incoming S. au-
reus. Hence, the increased release of antiadhesion extracellular
polysaccharides such as Ec300p in a bioﬁlm community could
constitute a molecular basis for colonization resistance and could
provide a direct advantage at the initial colonization stage com-
pared to that of strong colonizers, such as bioﬁlm-forming S. au-
reus.
Although the role of such antiadhesion molecules, which in-
terfere with the settling of colonizing bacteria, has been poorly
investigated, their widespread occurrence could play a signiﬁcant
role in bacterial competition and niche exclusion in multispecies
communities.Forinstance,Ec300pactivitycouldprovideadirect
advantage at the initial colonization stage compared to that of
strong colonizers, such as bioﬁlm-forming S. aureus.
A particularly intriguing aspect of our study is the restricted
activity spectrum of Ec300p toward Gram-positive bacteria. As
previously considered for the broad-host-range antiadhesion ac-
tivity of the group 2 capsule, interactions with negatively charged
Ec300p macromolecules could result in repulsive electrostatic
forcesonnegativelychargedbacterialsurfaces.However,S.aureus
mutants with an altered cell wall (tagO and dltA), leading to dif-
ferent global net surface charges, are still unable to form a bioﬁlm
in the presence of Ec300p. Other effects may therefore be in-
volved, including surface hydration, steric repulsion, hydropho-
bicity,orelectrondonor-electronacceptor(acid-base)properties,
reportedtobe10to100timesmoreimportantforbacterialadhe-
sion than other interactions (36). Alternatively, Gram-positive
bacteriagenerallydisplaymorepronouncedhydrophobicproper-
ties than Gram-negative bacteria and could be more sensitive to
the rise in surface hydrophilicity induced by Ec300p coating.
Surface-active molecules were proposed to be a promising
meansofpreventinginfectionbyinterferingwithpathogenadhe-
sion (8, 14, 15). However, use of broad-host-range antiadhesion
molecules could have undesirable effects. In this respect, the nar-
row host range of Ec300p could provide an interesting alternative
forpreventingcolonizationandbioﬁlminfectionbyS.aureusand,
potentially, other Gram-positive bacteria. Moreover, as opposed
to antibiotics and other toxins targeting vital cellular functions,
use of antiadhesion molecules could lower the selective pressure
upon bacterial ﬁtness, therefore limiting the arrival of resistant
mutants as selective pressure is signiﬁcantly lowered.
Inconclusion,ourresultsdemonstratethatbioﬁlmsconstitute
a reservoir of molecules that could play signiﬁcant roles in the
dynamic of commensal/pathogen interactions within mixed bac-
terial communities. Screening bioﬁlm extracts could be extended
to other bioﬁlm-forming organisms and reveal activities that
would otherwise go undetected. This not only would lead to a
better understanding of bioﬁlm biology but also could uncover
new interference molecules of potential biomedical interest.
MATERIALS AND METHODS
Bacterial strains, plasmids, and liquid growth conditions. The E. coli
naturalisolatesusedinthisstudyarelistedinTableS1inthesupplemental
materialandoriginatefrompreviouslypublishedcollections(37–40).The
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supplementalmaterial.Gram-positivestrainswereculturedintrypticsoy
broth (TSB) supplemented with 0.25% or 0.5% glucose (E. faecalis). All
other experiments were performed in 0.4% glucose-M63B1 minimal me-
dium (M63B1) or in lysogenic broth (LB) medium at 37°C, with appro-
priate antibiotics when required.
Puriﬁcation of planktonic and bioﬁlm extracts. (i) Planktonic su-
pernatants. Bacteria were cultured for 24 to 48 h in M63B1 and then
adjusted to an optical density (OD) of 3 (OD at 600 nm [OD600], 3).
Cultures were centrifuged for 10 min at 7500 rpm at 4°C, and the super-
natants were ﬁltered through a 0.2-m ﬁlter.
(ii)Bioﬁlmextracts.Continuous-ﬂowmicrofermentorscontaininga
removable glass spatula were used as described (http://www.pasteur.fr
/recherche/unites/Ggb/matmet.html) to maximize bioﬁlm development
and minimize planktonic growth. Inoculation was performed by dipping
the glass spatula for 5 min in a culture adjusted to an OD600 of 1 from
overnight bacterial cultures grown in M63B1 supplemented with the ap-
propriate antibiotics. The spatula was then reintroduced into the micro-
fermentor. After 72 h at 37°C, microfermentor medium (OD600  0.1)
was carefully discarded, and bioﬁlm biomass was rapidly resuspended in
the remaining 15 ml medium for 30 s. Under these particular conditions,
most tested E. coli strains developed thick mature bioﬁlms (1- to 4-fold
biomass variance), and occasional poor-bioﬁlm-forming strains were ex-
cluded from the analysis.
(iii) Nonconcentrated extract. The ﬁnal OD600 value was measured
andadjustedtoanOD600of3,andtheextractwascentrifugedandﬁltered
through a 0.2-m ﬁlter (see Fig. S1 in the supplemental material).
(iv)Concentratedextract.Nonconcentratedextractwasethanolpre-
cipitated and concentrated.
(v) Puriﬁed extract. Concentrated extract was puriﬁed on a DEAE
anion-exchange column, as described in reference 14.
Bioﬁlm-related assays. (i) Bioﬁlm inhibition assays. Overnight cul-
tures were adjusted to an OD600 of 0.1 before inoculating 50 l into 96-
wellpolyvinylchloride(PVC)plates(Falcon;BectonDickinsonLabware,
Oxnard,CA)andaddedata1:1ratioto50lofﬁlter-sterilizedbioﬁlmor
planktonicsupernatantequilibratedtoanOD600of3.Bioﬁlmswereleftto
grow for either 8 or 16 h at 37°C before quantiﬁcation as described in
reference 14.
(ii) Microtiter plate precoating assays. One hundred microliters of
bioﬁlm extract were inoculated into a 96-well PVC microtiter plate and
left to incubate for 24 h at 4°C. Bioﬁlm extract was removed, and micro-
titerplateswerewashed3timeswithsteriledeionizedwater.Exponential-
phase cultures were then adjusted to an OD600 of 0.06, inoculated into
precoatedmicrotiterplates,andlefttogrowfor16and24hat37°Cbefore
quantiﬁcation as described in reference 14.
(iii) Growth inhibition test. The inhibitory effect of ﬁlter-sterilized
supernatants and extracts was evaluated as decribed in reference 16.
Molecular characterization of the inhibitory compound. Molecular
cutoff analyses and proteinase K treatments were conducted as described
in reference 14. To determine the polysaccharide composition, bioﬁlm
extractswereﬁlteredthrougha0.2-mﬁlter,precipitatedwith3volumes
ofethanol,anddialyzedagainstdeionizedwater(10-kDacassettes;Pierce,
Rockford,IL).Totalamountsofneutralsugarswerequantiﬁedbyphenol-
sulfuricacidmethods,usingglucoseasastandard.Extractactivefractions
were puriﬁed and submitted to either sizing chromatography or compo-
sition analysis, as described in reference 14.
Generation of deletion and transcriptional fusions. Gene deletions
and replacement with an antibiotic resistance cassette in the different
strains of E. coli and lacZ-zeo fusion mutants in E. coli Ec300 were gener-
atedbytheredlinearDNAgenereplacementsystemandthe3-stepPCR
procedure described previously (41, 42).
Beta-galactosidaseassays.Beta-galactosidaseactivityonexponential-
andstationary-phasecellsand72-hbioﬁlmswereperformedasdescribed
in reference 43.
Mixed bioﬁlm assays. (i) Competition. Overnight LB cultures of
S.aureus,E.coliEc300,andE.coliEc300rfaHstrainsweremixedina1:1
ratio (OD600  1) before inoculation in a microfermentor (LB, 60 ml/h
ﬂowrate).Dilutionsofthebiomasscollectedatdifferenttimepointswere
plated in LB with and without suitable antibiotics.
(ii)Bioﬁlmcolonization.E.coliEc300bioﬁlmswerepregrownfor8h.
ThespatulawasthencarefullyremovedanddippedinanS.aureusculture
adjusted to an OD600 of 1 for 5 min. The mixed bioﬁlm was allowed to
grow 24 h more at 37°C in LB before recovery, and dilutions of the bio-
mass were plated in LB and in plates supplemented with suitable antibi-
otics.
Functional analysis of polysaccharide activity. (i) Initial adhesion
onglassslides.OvernightLBculturesofﬂuorescentS.aureuswerediluted
to an OD600 of 1 before being mixed in a 1:1 ratio with either different
E.coliEc300strainsor100g/mlofE.coliEc300ﬁlteredsterilizedbioﬁlm
extracts. The glass slides were incubated for 5 min and rinsed once in
deionizedwaterbeforemicroscopicobservation.Atleast10pictureswere
taken of each slide. Experiments were performed in triplicate. Bacteria
adhering to the glass surface were counted, and the total surface area
covered was estimated with ImageJ64 software developed by the NIH
(http://imagej64.mac.informer.com/).
(ii)Aggregationassay.S.aureuscultureswereadjustedtoanOD600of
3 by dilution with spent medium, and the aggregation assay was con-
ducted as described in reference 14.
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